Clinical features and antibiotic treatment of early-onset neonatal listeriosis

J Int Med Res. 2022 Aug;50(8):3000605221117207. doi: 10.1177/03000605221117207.

Abstract

Objective: To analyze the clinical features, efficacy of antibiotic treatment, and outcome of neonatal listeriosis.

Methods: This was a retrospective study that included all neonates diagnosed with listeriosis between January 2010 and December 2021.

Results: Nine male patients and five female patients were analyzed, including 11 preterm and 3 term infants. The mean gestational age was 34 ± 2.6 weeks (29 + 2-40 + 2 weeks), and the mean birth weight was 2392 ± 603 g (1370-3580 g). The maternal clinical manifestations included fever (13/14 [92.9%]), meconium-stained amniotic fluid (12/14 [85.7%]), and intrauterine fetal distress (11/14 [78.6%]). The neonates presented with fever (14/14 [100%]), generalized maculopapular rash (7/14 [50%]), and convulsions (8/14 [57.1%]). Laboratory tests showed leukocytosis (11/14 [78.6%]), monocytosis (9/14 [64.3%]), elevated C-reactive protein levels (13/14 [92.9%]), and thrombocytopenia (6/14 [42.9%]). Eight patients had central nervous system involvement, and Listeria monocytogenes was isolated from the blood in all cases. Empiric antibiotic therapy consisted of a combination of third-generation cephalosporins and penicillin or vancomycin. Four patients died, and 10 patients were cured.

Conclusions: Preterm infants were more susceptible to listeria infection than term infants, with most having multiple organ injuries. Combined antibiotic application improved the effectiveness of treatment.

Keywords: Antibiotic treatment; listeriosis; meningitis; neonate; preterm infant; septicemia.

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Infant, Premature
  • Listeria monocytogenes*
  • Listeriosis* / diagnosis
  • Listeriosis* / drug therapy
  • Male
  • Retrospective Studies

Substances

  • Anti-Bacterial Agents